Biotechnology company Group K Diagnostics (GKD) said on Tuesday that it plans to introduce improved clinical experiences to patients and caregivers alike under a partnership with Health Network Laboratories (HNL), a laboratory medicine service company.

Under the agreement, patients seeking liver function testing may participate in a clinical trial using GKD's microfluidic point-of-care device, the MultiNostic.

To participate in the free clinical trial, patients 18 years or older can sign up at two of HNL's Patient Service Centers located at 1630 N. Cedar Crest Boulevard and 3219-B Schoenersville Road and Avenue C.

The clinical trial will substantiate GKD's MultiNostic's accuracy, effectiveness, operational efficiencies as well as analyse the resulting clinical implications.

In a clinical setting, GKD's MultiNostic is expected to allow patients to receive appropriate care sooner and reduce the extent of the providers' administrative functions. The technology's turnaround time and decreased administrative burden will enable the provider to impact the patient experience. The technology promises accurate results in 20 minutes or less, using blood from only a simple finger stick.